Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

CUSIP: 00773U108

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22,163,711
Total 13F shares
95,172,816
Share change
+14,197,796
Total reported value
$980,341,669
Put/Call ratio
64%
Price per share
$10.30
Number of holders
158
Value change
+$112,519,116
Number of buys
98
Number of sells
53

Security key

00773U108

Report period

Q3 2020

Institutions

158

Top holders

10

Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
35%
7,801,641
$162,898,000 30 Jun 2020
13F
Avoro Capital Advisors LLC
13F
Company
34%
7,585,000
$158,375,000 30 Jun 2020
13F
Versant Venture Management, LLC
13F
Company
32%
7,003,892
$146,241,265 30 Jun 2020
13F
RTW INVESTMENTS, LP
13F
Company
31%
6,790,027
$141,776,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
27%
5,910,684
$123,416,000 30 Jun 2020
13F
Sonic Fund II, L.P.
13F
Company
19%
4,112,355
$85,866,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
17%
3,846,430
$80,312,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
16%
3,475,116
$72,560,000 30 Jun 2020
13F
ORBIMED ADVISORS LLC
13F
Company
15%
3,290,744
$68,711,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
9.6%
2,124,648
$44,363,000 30 Jun 2020
13F
Casdin Capital, LLC
13F
Company
8.4%
1,865,000
$38,941,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
8.4%
1,863,474
$38,909,000 30 Jun 2020
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
7.9%
1,746,500
$36,467,000 30 Jun 2020
13F
UBS Group AG
13F
Company
7.5%
1,662,350
$34,709,000 30 Jun 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
6.5%
1,437,028
$30,005,000 30 Jun 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
5.6%
1,239,360
$25,878,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
5.1%
1,139,697
$23,797,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.7%
1,047,083
$21,863,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
4.3%
948,956
$19,815,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
4.1%
900,000
$18,792,000 30 Jun 2020
13F
Ghost Tree Capital, LLC
13F
Company
4.1%
900,000
$18,792,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
3.9%
864,130
$18,043,000 30 Jun 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
3.8%
833,895
$17,412,000 30 Jun 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
3.5%
769,508
$16,067,327 30 Jun 2020
13F
WS MANAGEMENT LLLP
13F
Company
3.2%
703,000
$14,679,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.6%
582,948
$12,172,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
2.3%
505,665
$10,558,000 30 Jun 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.3%
500,000
$10,440,000 30 Jun 2020
13F
Rhenman & Partners Asset Management AB
13F
Company
2.3%
500,000
$10,440,000 30 Jun 2020
13F
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA)
13F
Company
2.2%
480,000
$10,022,000 30 Jun 2020
13F
First Light Asset Management, LLC
13F
Company
2.1%
469,798
$9,809,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2%
452,396
$9,447,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
1.8%
408,901
$8,538,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.8%
396,817
$8,286,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
1.6%
355,681
$7,426,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
1.5%
327,773
$6,844,000 30 Jun 2020
13F
Assenagon Asset Management S.A.
13F
Company
1.4%
320,215
$6,686,000 30 Jun 2020
13F
FMR LLC
13F
Company
1.3%
296,142
$6,183,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
1.3%
293,826
$6,136,000 30 Jun 2020
13F
BARCLAYS PLC
13F
Company
1.3%
282,820
$5,905,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.2%
272,957
$5,699,000 30 Jun 2020
13F
Allianz Asset Management GmbH
13F
Company
1.1%
239,608
$5,002,000 30 Jun 2020
13F
S.c.a. Candriam
13F
Individual
1%
228,575
$4,773,000 30 Jun 2020
13F
FEDERATED HERMES, INC.
13F
Company
1%
227,691
$4,754,000 30 Jun 2020
13F
Soleus Capital Management, L.P.
13F
Company
0.99%
218,723
$4,566,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.75%
165,713
$3,460,000 30 Jun 2020
13F
COWEN AND COMPANY, LLC
13F
Company
0.72%
160,216
$3,345,000 30 Jun 2020
13F
Burrage Capital Management LLC
13F
Company
0.7%
156,012
$3,258,000 30 Jun 2020
13F
Swiss National Bank
13F
Company
0.6%
134,000
$2,798,000 30 Jun 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.59%
130,870
$2,733,000 30 Jun 2020
13F

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2020

As of 30 Sep 2020, Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by 158 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,172,816 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, Versant Venture Management, LLC, BlackRock Inc., STATE STREET CORP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Sonic Fund II, L.P., and Casdin Capital, LLC. This page lists 158 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
140
Q3 2020 holders
158
Holder diff
18
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .